ACCELERATING A CURE FOR PANCREATITIS through Innovative Therapies and Sustainable Funding

We invest in innovative companies that are developing therapies to improve the lives of all children and adults suffering from pancreatitis.

Every Mission Cure Capital Investment is Evaluated and Vetted by our

World-Renowned Advisors and Key Opinion Leaders

What is Pancreatitis?

Pancreatitis is an inflammatory process of the pancreas. When the pancreas functions correctly, it creates digestive enzymes which are released into the small intestine to begin digestion. Pancreatitis occurs when these enzymes are prematurely activated in the pancreas, essentially digesting the organ, damaging tissue and causing inflammation. The condition can be acute or chronic, causing severe abdominal pain.

No Treatment, No Cure

Because there are no treatments that prevent or stop pancreatitis, the pain and inflammation continue.

Chronic pancreatitis is a progressive degenerative disorder that causes digestive dysfunction, malnutrition, fibrosis, diabetes and a significantly increased risk of pancreatic cancer.

JOIN US to Create Solutions

Together, we can discover and advance effective treatments, put an end to pancreatitis pain and suffering and significantly improve the lives of patients and their families.

As patients, we are relentless. As impact investors, we are focused. We deploy resources and expertise to achieve our goals quickly and efficiently

OUR PORTFOLIO COMPANIES

As early stage investors, Mission Cure Capital expects above-market returns, but our life science portfolio companies are much more than investment opportunities. As chronic pancreatitis patients, family members and impact investors, we fuel problem-solvers who share our urgency and measure success by improvements in disease progression and quality of life.

JOIN US TODAY

Submit a Proposal

Mission Cure Capital supports innovators who are ready to test new ideas, build evidence of what works, and advance the best solutions.

Invest

We invest in commercially promising research and development opportunities that will improve the lives of children and adults suffering from pancreatitis.